StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.95−0.02 (-2.05%)

Close on Nov 20, 2026Market cap $18.30MP/E –Yield –

Cocrystal Pharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2012 it was $7.22M, up 168.9% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2012Dec 31, 2012$7.22M+168.9%
FY2011Dec 31, 2011$2.69M-60.7%
FY2010Dec 31, 2010$6.83M–

More Cocrystal Pharma figures

See a number that looks wrong?